SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Erkut, Z A
Right arrow Articles by Swaab, D F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erkut, Z A
Right arrow Articles by Swaab, D F
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis

Z A Erkut

Netherlands Institute for Brain Research, Meibergdreef 33, Amsterdam 1105 AZ, The Netherlands

E Endert

Laboratory of Endocrinology, Department of Clinical Chemistry, Academical Medical Center of Amsterdam University, Amsterdam, The Netherlands

I Huitinga

Netherlands Institute for Brain Research, Meibergdreef 33, Amsterdam 1105 AZ, The Netherlands

D F Swaab

Netherlands Institute for Brain Research, Meibergdreef 33, Amsterdam 1105 AZ, The Netherlands, t.eikelboom{at}nih.knaw.nl

Hypothalamo-pituitary-adrenal (HPA) axis activity is altered in patients with multiple sclerosis (MS), resulting in elevated basal levels and enhanced response of cortisol in stimulation tests. HPA axis hyperactivation in MS is thought to be the result of complex interactions of genetic, immunologic, and neuroendocrinological mechanisms. In order to investigate whether cytokine levels in the central nervous system are associated with the activation of the HPA axis in MS, we measured cortisol, interleukin (IL)-6, IL-10 and TNF-{alpha} levels in postmortem cerebrospinal fluid (CSF) of 18 patients with severe MS and 50 controls. We also investigated the cortisol and cytokine levels in the CSF of a group of MS patients and controls who died with sepsis, in order to see whether acute infectious situations affect the association between cortisol and cytokines. The cortisol levels in MS patients were increased by 80% in comparison to controls (p =0.008). There was no difference in IL-6 levels between the groups, while IL-10 and TNF-{alpha} levels of the majority of subjects were below detection limits. There was a positive correlation between cortisol and IL-6 only in control patients with sepsis (r=0.89, p =0.019), but not within the MS patients with sepsis or MS and control groups without sepsis. Cortisol levels in postmortem serum and CSF were highly correlated (r >0.78, p <0.001). We concluded that the basal level of cortisol is significantly increased in the CSF of MS patients and that IL-6 is not responsible for this rise. The relationship between cortisol and IL-6 in sepsis is discussed.

Key Words: HPA axis • human • postmortem • stress

Multiple Sclerosis, Vol. 8, No. 3, 229-236 (2002)
DOI: 10.1191/1352458502ms797oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
F. Zellini, G. Niepel, C. R Tench, and C. S Constantinescu
Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing--remitting multiple sclerosis
Multiple Sclerosis, December 1, 2009; 15(12): 1442 - 1449.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. M. L. van Winsen, D. F. R. Muris, C. H. Polman, C. D. Dijkstra, T. K. van den Berg, and B. M. J. Uitdehaag
Sensitivity to Glucocorticoids Is Decreased in Relapsing Remitting Multiple Sclerosis
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 734 - 740.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Xu, L. Lecanu, Z. Han, Z. Yao, J. Greeson, and V. Papadopoulos
Inhibition of Adrenal Cortical Steroid Formation by Procaine Is Mediated by Reduction of the cAMP-Induced 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Messenger Ribonucleic Acid Levels
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1148 - 1157.
[Abstract] [Full Text] [PDF]



Advertisement